Erythema dyschromicum perstans (ashy dermatosis) during the treatment with infliximab in a child with Crohn disease

Michał Sobjanek; Magdalena Lange; Igor Michajłowski; Joanna Lakomy; Roman Nowicki

doi:10.5114/dr.2014.41068

eISSN: 2084-9893
ISSN: 0033-2526

Dermatology Review/Przegląd Dermatologiczny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

1/2014
vol. 101

Send email

Copy url:

abstract:

Original paper

Erythema dyschromicum perstans (ashy dermatosis) during the treatment with infliximab in a child with Crohn disease

Michał Sobjanek

,

Magdalena Lange

,

Igor Michajłowski

,

Joanna Lakomy

,

Roman Nowicki

Przegl Dermatol 2014, 101, 27–30
[Polish version: Przegl Dermatol 2014, 101, 31-34]

DOI: https://doi.org/10.5114/dr.2014.41068

Online publish date: 2014/03/13

View full text Get citation

PlumX metrics:

Introduction. Erythema dyschromicum perstans (EDP) or ashy dermatosis is a rare, benign acquired disease characterized by macular hyperpigmentations. The cause of EDP is unclear although some drugs, toxic agents and internal disorders have been associated with this dermatosis.

Objective. Presentation of the first case of the association between EDP and Crohn disease treated with infliximab.

Case report. We present a case of a 15-year-old boy with Crohn disease who was treated with infliximab. During the treatment asymptomatic, hyperpigmented macules on the trunk were observed. Based on clinical and histopathological features the diagnosis of erythema dyschromicum perstans was established.

Conclusions. Erythema dyschromicum perstans may be associated with Crohn disease and infliximab.

keywords:

Erythema dyschromicum perstans (ashy dermatosis) during the treatment with infliximab in a child with Crohn disease

Michał Sobjanek , Magdalena Lange , Igor Michajłowski , Joanna Lakomy , Roman Nowicki

erythema dyschromicum perstans, ashy dermatosis, Crohn disease, infliximab

Michał Sobjanek

,

Magdalena Lange

,

Igor Michajłowski

,

Joanna Lakomy

,

Roman Nowicki